Find uplifting stories about heroes, innovations, and solutions
10 results for "psychedelic medicine"
A groundbreaking clinical trial found that a single dose of psilocybin helped people struggling with cocaine addiction stay sober longer than a placebo. This could be the first real treatment option for the rising tide of stimulant overdoses claiming more lives each year.
A presidential order is accelerating research on ibogaine, a plant-based treatment showing promise for veterans with PTSD and people battling depression. The FDA says approval could come within months instead of years.
A new executive order accelerates research into psychedelic medicines for mental illness, prioritizing veterans facing treatment-resistant PTSD and depression. The move ends decades of federal prohibition and could offer hope to the 17 veterans who die by suicide every day.
%2Fhttps%3A%2F%2Ftf-cmsv2-smithsonianmag-media.s3.amazonaws.com%2Ffiler_public%2F1b%2Fd1%2F1bd13e5f-b965-47b7-85a7-c1e653cecb61%2Ftobacco.jpg)
Researchers engineered tobacco plants to produce five therapeutic psychedelics, making it easier to study treatments for depression and PTSD. The breakthrough could replace harmful harvesting practices with sustainable medicine production.
Researchers engineered a single tobacco plant to produce five therapeutic psychedelic compounds, creating a sustainable alternative to harvesting endangered toads and mushrooms. This biological factory could revolutionize mental health treatment access.
Massachusetts General Hospital just launched a clinical trial to find out if adding a human "coach" during ketamine therapy makes the treatment work better for depression. The study could reshape how millions access mental health care.
A groundbreaking depression treatment using psilocybin is showing promising results in clinical trials, potentially becoming the first psychedelic therapy approved by the FDA. Two major studies confirm the compound helps patients with severe depression find relief.
A psychedelic treatment could soon offer new hope for people with severe depression who haven't found relief from traditional medicines. Two major clinical trials show the psilocybin therapy helped patients improve more than standard care.
A single dose of DMT, a natural compound in ayahuasca, rapidly reduced depression symptoms in a clinical trial and kept working for weeks. Scientists say the fast-acting treatment could help millions for whom current medications don't work.
A groundbreaking trial in the UK found that a single dose of DMT paired with therapy rapidly reduced depression symptoms in patients, with improvements lasting at least three months. Nearly half the participants achieved remission, opening new hope for faster, more accessible mental health treatment.